Neurol. praxi. 2012;13(1):10-13

Persistent migraine aura without infarction

MUDr.Jiří Mastík
1 . neurologická klinika LF MU a FN u sv. Anny, Brno

Persistent aura without infarction (PAWI) is among rare complications of migraine. The diagnostic criteria include: a history of attacks of migraine

with aura; an aura persisting for more than one week; and a neuroradiological examination failing to demonstrate migrainous infarction. The

most common symptoms of aura are visual and may persist for months or years. The differential diagnostic process involves ruling out complications

of migraine (migrainous infarction, status migrainous) as well as some eye diseases (such as vitreous opacities), visual hallucinations in

psychiatric diseases, hallucinogen persisting perception disorders and some other rarer causes. An effective treatment for PAWI is not known;

acetazolamide, valproic acid and topiramate are recommended. The author reports two interesting cases of migraineurs with chronic visual

aura. A 29-year-old woman has had migraine with aura since puberty. In July 2010, she developed a persistent visual disturbance characterized

by visual snow – speckling, combined with flashing and colour effects. A 22-year-old man with occasional migraine with aura (visual, sensory

and dysphasic) has suffered since early childhood from a persistent visual disturbance characterized by speckling, when "the outside world is

seen as if behind this veil". The condition is accompanied by symptoms of depersonalization and derealization. Both patients were evaluated

thoroughly. Ophthalmological examination, CT, MRI, EEG, CSF and laboratory tests, psychological and psychiatric examinations were mostly

negative. Permanent visual problems significantly complicate the life in both our patients. Repetitive transcranial magnetic stimulation appears

to be a promising method for affecting persistent visual aura caused by visual cortex hyperexcitability.

Keywords: migraine with aura, migraine complications, persistent aura without infarction, visual snow

Published: February 14, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mastík J. Persistent migraine aura without infarction. Neurol. praxi. 2012;13(1):10-13.
Download citation

References

  1. Abraham HD. Visual phenomenology of the LSD flashback. Arch Gen Psychiatry 1983; 40: 884-889. Go to original source... Go to PubMed...
  2. Bereczki D, Kollár J, Kozák N, Viszokay K, Barta Z, Sikula J, Magyar MT. Cortical spreading edema in persistent visual migraine aura. Headache 2008; 48: 1226-1229. Go to original source... Go to PubMed...
  3. Brighina F, Pizza A, Daniele O, Sierro B. Modulation of visual cortical excitability in migraine with aura: effects of 1 Hz repetitive transcranial magnetic stimulation. Exp Brain Res 2002; 145: 177-181. Go to original source... Go to PubMed...
  4. de Almeida RF, Leao IA, Gomes JB, da Silva AA jr., Teixeira AL. Migraine with Persistent Visual Aura: Response to Furosemide. Clinics (Sao Paulo) 2009; 64: 375-376. Go to original source... Go to PubMed...
  5. Evans RW, Lay CL. A persistent migraine aura. Headache 2000; 40: 696-698. Go to original source... Go to PubMed...
  6. Haan J, Sluis P, Sluis LH, Ferrari MD. Acetazolamide treatment for migraine aura status. Neurology 2000; 55: 1588-1589. Go to original source... Go to PubMed...
  7. Haas DC. Prolonged migraine aura status. Ann Neurol 1982; 11: 197-199. Go to original source... Go to PubMed...
  8. Headache Classification Subcommittaee of the International Headache Society: The International Classification and diagnostic criteria of headache disorders. 2nd edition. Cephalalgia. 2004; 24(1): 160s.
  9. Chen WT, Lin YY, Fuh JL, Hämäläinen MS, Ko YC, Wang SJ. Sustained visual cortex hyperexcitability in migraine with persistent visual aura. Brain 2011; 134: 2387-2395. Go to original source... Go to PubMed...
  10. Chen WT, Fuh JL, Lu SR, Wang SJ. Persistent migrainous visual phenomena might be responsive to lamotrigine. Headache 2001; 41: 823-825. Go to original source... Go to PubMed...
  11. Klüver H. Mechanisms of hallucinations. In: McNemar Q, Merrill MA (eds) Studies in personality. Contributed in honor of Lewis M. Terman. McGraw-Hill, New York-London 1942: 175-207.
  12. Lerner AG, Kladman I, Kodesh A, SigalM, Shufman E. LSDinduced Hallucinogen Persisting Perception Disorder treated with clonazepam: two case reports. Isr J Psychiatry Relat Sci 2001; 38: 133-136. Go to PubMed...
  13. Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Pearlman SH, Fischell RE, Ruppel PL, Goadsby PJ. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol 2010; 9: 373-380. Go to original source... Go to PubMed...
  14. Liu GT, Schatz NJ, Galetta SK, Volpe NJ, Skobieranda F, Kosmorsky GS. Persistent positive visual phenomena in migraine. Neurology 1995; 45: 664-668. Go to original source... Go to PubMed...
  15. Luda E, Bo E, Sicuro L, Comitangelo R, Campana M. Sustained visual aura: a totally new variation of migraine. Headache 1991; 31: 582-583. Go to original source... Go to PubMed...
  16. Podoll K, Dahlem M, Haas DC. Persistent migraine aura without infarction - a detailed description. Webpage from Migraine Aura Foundation website, 2005.
  17. Relja G, Granato A, Ukmar M, Ferretti G, Antonello RM, Zorzon M. Persistent aura without infarction: description of the first case studied with both brain SPECT and perfusion MRI. Cephalalgia 2005; 25: 56-59. Go to original source... Go to PubMed...
  18. Rothrock JF. Successful treatment of persistent migraine aura with divalproex sodium. Neurology 1997; 48: 261-262. Go to original source... Go to PubMed...
  19. Rozen TD. Treatment of a prolonged migrainous aura with intravenous furosemide. Neurology 2000; 55: 732-733. Go to original source... Go to PubMed...
  20. Siegel RK, Jarvik M. Drug-induced hallucinations in animals and man. In: Siegel R, West L (eds) Hallucinations: Behavior, experience, and theory. John Wiley and Sons, New York, NY 1975. 81-161.




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.